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Mutations in the type VII collagen gene (COL7A1) are 
known to underlie different forms of the inherited 
blistering skin disease dystrophic epidermolysis bul-
losa (DEB). Most COL7A1 mutations are unique to 
individual families, and therefore it is usually neces-
sary to screen all118 exons of the gene to determine 
the molecular pathology in a patient with DEB. This 
study aimed to identifY any recurrent mutations in 
COL7A1 that might be applicable to mutation-detec-
tion strategies in these patients. Mutational analysis 
was undertaken in 23 British patients with autosomal 
recessive DEB using PCR amplification of genomic 
DNA followed by heteroduplex analysis, nucleotide 
sequencing, and restriction site analysis. Two recur-
rent mutations were identified: R578X (6 of 46 alleles) 
M utations in the gene encoding type VII collagen (COL7 Al), the major component of anchoring fibrils a~ the dermoepidermal junction (Keene el al , 1987; Burgeson, 1993), are known to under-lie both autosomal dominant and autosomal 
recessive forms of the inJ1erited blistering skin disease dystrophic 
epidermolysis bullosa (DEB) (Christiano and Ditto, 1996b). Al-
though more than 100 pathogenetic COL 7 Al mutations in DEB 
have been reported, most are unique to individual families, with no 
mutational hot spots so far reported in this gene (Ch.ri.stiano and 
Uitto, 1996a, 1996b) . COL7 A1 consists of 1.18 exons, the highest 
number of exons in any gene published to date (Christiano et a/, 
1994). Screening all exons of this gene for mutations in patients 
with DEB is therefore time-consuming, labor-intensive, and expen-
sive. The purpose of this stndy was to identifY any recurrent 
mutations in COL7A1 in British patients with recessive DEB that 
n1.ight be applied to future mutation-detection strategies. Haplotype 
analysis in the families studied was also performed to establish 
whether recurrent mutations were propagated on mutant ancestral 
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and 7786delG (7 of 46 alleles) . Haplotype analysis 
revealed that the mutations existed on similar allelic 
backgrounds in different patients, consistent with 
propagation of common British ancestral haplotypes, 
although R578X and 7786delG also have been de-
scribed in DEB patients from other ethnic back-
grounds. Given the high relative frequency of these 
two COL7A1 mutations, British patients with reces-
sive DEB should be screened initially for these nucle-
otide changes by PCR amplification of genomic DNA 
and restriction analysis before more exhaustive 
screening of COL7A1. Key words: basement membrane 
zone/blistering disorder/DNA- based prenatal testing/genetic 
skin disease.] Invest Dermatol 109:246-249, 1997 
alleles within the British population or whether they had arisen as 
mutational hot spots in COL7 A1. 
MATERIALS AND METHODS 
Clinical Analysis Twenty-three patients witb recessive DEB (1 0 male, 
13 female; ages 2-38 y) were included in tlus study. All were of British 
Anglo-Saxon ancestry and were not known to be related, and there was no 
history of consanguinity in any of the families. Al l patients w ere examined 
in the epidermolysis bullosa clinic at St. Jolm's Institute of Dem1atology. 
The diagnosis of recessive DEB was determined in each case by the family 
constellation and by skin biopsy specimens showing absent or attenuated 
immw1ostaining for type VII collagen at the dermoepidermal junction 
(Heagerty et al, 1986), as well as absent or poorly fom1ed anchoring fibrils 
beneath the lamina densa on electron nucroscopy (Tidman and Eady, 1985). 
Genomic DNA was extracted from peripheral blood lymphocytes of the 
patients and immediate f.1mily members by standard methods (Sambrook el 
a/, 1989). In two families, genomic DNA was also extracted from chorionic 
vill.i in two pregnancies at risk for recurrence of recessive DEB, as described 
previously (Dunnill et a/, 1995). 
Molecular Analysis Total DNA was used as a template for amplification 
of genomic sequences of COL7Al. Pairs of oligonucleotide primers span-
ning all 118 exons of the gene were synthesized on the basis of intronic 
sequences to generate polymerase cbain reaction (PCR) products (GenBank 
no. L23982). Specifically, exon 13 and exons 103/104 (see ReSII!ts) were 
amplified using the following primers: for exon 13, sense primer 5'CCT-
TCTCACTCTGCGTCCCT3' and antisense primer 5'AACCAGGACCA-
GAGTGAGGC3'; for exons 103/104, sense primer 5'CGGGCTCGTTG-
TATTCTAAG3 ' and antisense primer S'CAAAAGCTACCACACT-
GGTG3'. For PCR amplification, apprm.:imately 250 ng of genomic DNA 
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was used as the template under standard conditions, including 1 OX bufFer 
(Perkin-Elmer Cetus, Norwalk, CT), 4% dim ethylsul foxide. and 1 U Taq 
polymerase (Perkin-Elmer Cetus) in a tota l vo lume of 25 J.Ll. T he ampli fi -
cation conditioJlS for both sets of primers were 94°C for 5 min , foll owed by 
38 cycles of94°C for 45 s, 55°C for 45 s, and 72°C for 45 s in an Omn.iGenc 
thermal cycler (Hybaid Ltd. , Teddington, Middlesex, UK). Five-microli ter 
aliquots of PCR products were analyzed by 2% agarose gel electrophoresis. 
Aliquots of 3- 8 J.Ll of each sample were prepared for hcteroduplex analysis 
using conformation-sensitive ge l electrophoresis (Gangu ly cl al. 1993) and 
were v isualized with cthid.ium bromide staining. Samples containing het-
eroduplexes were subj ected to direct sequencing by an ABJ automated 
sequencer (Warrington, UK). The exon 13 and exon l04 mutations (sec 
R esults) abolished an X/tol and a Bsajl restriction enzym e site, respectively. 
AEquots of 5-12 ILl of the appropriate PCR products were used fo r 
restriction endonuclease digestion with the corresponding enzyme, accord-
ing to the manufacturer's instructions (New England Biolabs, Beverly , MA) . 
Diges tion products were examined by 2% aga rose ge l electrophoresis and 
were visualized with erltid.ium bromide . 
Haplotype Analysis T hree in tra genic COL7 Al polymorphisms and two 
flanking polymorphisms nea r the COL7A1 locus at 3p2 1 were studied. For 
the intragenic marke rs, genomic DNA was used to ampli fy with PC R exon 
21, exons 28 - 31, and exons 83-85; and for the flankin g markers, DNA 
sequences incorporating D3S2 and D3 F22 were ampli fied. 'PCR. conditions 
were identica l to those used to ampli fY exon "1 3 and exons 103/104. 
Annealing temperatures were 55°C for all PCR reactions except for D3F22 
(60°C). AEquots of 5 JLI ofPCR products were ana lyzed by electrophoresis 
on 2% agarosc gels, after whkh 5-1 2 J.Ll of each sample was digested with 
the fo llowing restriction endonucleases, accord ing to the manufacturer' s 
recommendations (N ew England Biolabs): exon 21 w ith Ptmll , exons 
28-3 1 and D3S2 with Mspl , exons 83- 85 with Eco0109, and D3F22 with 
Hiudlll (Christiano et a/ , 1996) . T he resulting digestion products were 
examined on 2% agarose gels sta ined with etludium bromide. 
To provide furth er information about the haplotypes of rhe f.1 milies 
studied, we analyzed the fo llowing five sets of microsatell.i te markers close 
to tl1e COL7Al locus at 3p21: D3SJ029, D3S 1076, D3S1235, D3S1573, 
and D3S1581 (Research Genetics Inc., Huntsville , AL) . The marker 
D3S1235 was examined by end-labeling the sense primer with [y-33 P]dATP 
by standard metl10ds (Sambrook et a/, 1989). T he PCR amplification 
conditions were: 94°C for 7 min, followed by 27 cycles of 94°C for 1 min, 
59°C for 1 nun , and 72°C for 1 min. Samples for analysis were prepared by 
adding 6 J.Ll of PC R product to 4 J.L I of stop solu tion (Amersham, Little 
Chalfont, UK) and heating to 95 °C for 5 min . Five microli ters of each 
sample was then run on 6'}',, acry lamidc and visualized by exposure to 
Hyperfi lm (Amersham) . The other fo ur microsatellitc markers were PCR 
amplified from genomic DNA using the fo llowing conditions: 94°C for 5 
min, followed by 38 cycles of94°C for 45 s, anneal ing temperature for 45 s, 
and 72°C for 45 s. Annealing temperatures were 55°C for D3Sl029, 
D3S1076, and D3Sl573 and 57°C for D3S1581. Eight microli ters of each 
sample was run on 6'X. nondenaturing acrylamide gels and visual.ized using 
ethidium bromide sta ining. 
R ESULTS 
Identification of Two Recurrent COL7A1 Mutations Nu-
cleotide sequencing of PCR products spanning exon 13 a11d 
displaying a h e teroduplex o n conform ation-sensitiv e gel electro-
phoresis ana lys is reveale d a C - to-T transition at position 1732 in 
exon 13 of COL7A1 (GenBank no. L02870), w hic h conve rts an 
argini11 e residue to a stop codon (CGA to TGA) . Tills mutation, 
R578X, ab o lish es a restriction enzyme site for X hoi (Fig ta). After 
d emonstrating this mutation by nucleotide sequ e n cing in two 
unrelated patients, we screen ed the re m ainder of the patients b y 
res tri c tion analysis with X /wl to assess the presen ce or absen ce of 
R578X. Screening of th.e 23 British patients w ith recessive DEB 
revea led tlus mutation on 6 of 46 a lle les (13%) . In a ll cases, patients 
were h eterozygous for the mutation. 
Patients display ing heterodupl ex bands in th e PCR produ cts 
spanning exons 103/ 104 were fo und to have d e letion of a G residue 
at position 7786 on nucleotide sequencin g. This mutation , 
7786d e lG, resul ts in a fi.·ame sluft and a down stre am premature 
te rmination codon in ex on 106 and causes loss of a restriction 
enzyme site for Bsa)l (Fig 111) . After i.Jutial ide n tification of th e 
mutation b y sequen cing in two patients , tlus e n zym e was use d to 
screen all patients in the study. We identifie d 7786delG on 7 of 46 
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Figure 1. The R578X and 7786deiG mutations can be identified b y 
restriction endonuclease analysis. (a) The mutation R578X abolishes 
an Xilol site . ln the f.1ther, unaffected sibling, and unrelated healthy control 
(la11cs 1,3,5), the 294-bp PCR product is diges ted to 186-bp and 108-bp 
fragments. T he mother and proband (/a11es 2,4) have both of these fragments 
in addition to tl1e 294-bp product, indicating that they are heterozygous for 
this mutation . (b) The mutation 7786deiG causes loss of a Bsa)l site . T he 
mother, unaffected sibling, and unrelated healthy control (laues 2,3,5) have 
< 60-bp fragments from tl1e 512-bp PCR product. T he father and proband 
(/mtcs 1,4) have these digestion products in addition to a 120-bp fragment, 
indicating that they are heterozygous for the mutation . MW, c/>X174 Haeiii 
molecular-weight marker. 
(15%) alleles studie d , with all p atients being heterozygous for the 
mutation. 
Evidence for Propagation of Common British Ancestral 
Mutant Alleles Haplotype analysis of patients and family mem-
bers with th e R578X mutation are shown u1 Fig 2 (families A to 
D) . R578X was present on an identical h ap lotype background ii1 a ll 
affected families for the three intrage1uc and two flanking markers 
studie d . 
Haplotype analysis in affected families with. 7786delG demon-
strated that t lli s mutation was present on two haplo type back-
g rounds, w hich differed from each otl1e r only at th e flanking 
COL7A1 mat·ke r, D3S2 (Fig 2 ; fam ilies and pa tients D to J) . 
Microsatellite markers D3S1235 and D3S1581 were inform ative in 
· th ese families, w h ereas th e remaining three microsatellite markers 
w e re n onin fon11ative . 
Evidence for Recombination in the Flanking Marker D3F22 
in Two Families Eviden ce was found for recombination in th.e 
COL7 Al flanking m arker D3F22 in two fu milies with the R578X 
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ex 83-85 
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Family C 
R578X 
ex 21 
ex 28-31 
ex 83-85 
0352 
03F22 
Family F 
7786deiG 
ex 21 
ex 28-31 
ex 83-85 
0352 
D3F22 
0351235 
0351581 
Family J 
7786deiG - -
ex 21 
ex 28-31 
ex 83-85 
0352 
03F22 
0351235 
0351581 
Figure 2. Evidence for propagation of common ancestral alleles bearing the R578X and 7786delG mutations. Haplotype analysis in affected 
fa milies is shown usin g COL7A1 in tragcnic markers in exon 21, exons 28-31, and exons 83- 85, and flankin g markers at D3S2 and D3F22. R.578X occurs 
on iden tical haplotypes in families A, B, C, and D. Mutation 7786delG is present on two haplotypes tha t differ only at the D3S2 locus: " - " in fiunilies D, 
E, and F and in patien ts G and H, and"+" in fa milies I and]. Microsatellite markers D3S1235 and D3Sl581 are informative for 7786delG, but not for R.578X. 
T he other three rnicrosatelli te markers examined (see text) were noninfo rmati ve for both mutations. Recombination at the D3F22 locus is no ted in families 
B and C (*), and recombination at the D3S1581 locus has occurred in famil y D (*) . 
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mutation , occurring in 3 of 34 (9%) alleles of o ffspring in the 
families studied (Fig 2; families Band C). Recombination was also 
o bserved in th e microsatellite marker D3S1581 in o ne individual 
with 7786delG (Fig 2; family D). 
DISCUSSION 
In this study, we have demonstrated the presence of two recurrent 
mutations in COL7 Al in British patients w ith recessive DEB, both 
of which result in premature termination codons of translation on 
the affected alleles. T he mutations, R578X and 7786deiG, w ere 
found with a relatively high freq uency in the population studied, 
with all.elic fre quen cies of 13% and 15%, respectively. 
The mutation R578X results fro m a C-to-T transition at a CpG 
dinucleotide site in exon 13 of COL7A1. As with other CpG 
dinucleotides, this site may be susceptible to m ethylatio n-induced 
deamination of 5-methylcytosine to ca use transition to aT residue, 
which may be the mechanism that genera tes this particular prema-
ture termin ation codon (Cooper and Youssoufian , 1988). Similar 
mutational mechanisms exist widely throughout the genome, and 
the recurrence of R578X in COL7 Al may represent a further 
example of a mutational hot spot. In support of this, R5 78X has 
been demonstrated previo usly in DEB patients from a different 
etlmic background (Dunnill et a/, 1994). Our haplotype analysis 
demonstrated, however, that R578X was present on identical 
all elic backgmunds in the four families studied , consistent with its 
existence o n a commo n British mutant ancestral aLl ele . Although 
the mutation may have arisen originally at a muta tional hot spot, 
the haplotypes in these families suppor t its propagation through the 
British gene pool. 
The 7786deiG mutatio n resul ts in a premature termination codo n 
in exon 106 and would also be expected to result in greatly 
diminished syn thesis of type Vlf collagen through reduced steady-
state mRNA levels (Baserga and Benz, 1988; Urlaub et a/, 1989; 
C heng e/ a/, 1 990) . T his mutation arises in the vicinity of an 
adj acent G residu e and two ne ighboring repeated triplet sequences 
of C residues . Deletion of one of the G residues, as occurs in this 
mutation , m ay therefore h ave resulted fi·om slipped mispairing 
duting DNA replication (Krawczak and Cooper, 1991). T his 
sequence-directed m echanism for the gener·ation of 7786deiG is 
supported by the identification of the sam e mutatio n in an indi vid-
ual of a different ethnic background (Christiano and Uitto, 1996b) . 
N evertheless, in tlus study, 7786delG was found in the families 
studi ed on two similar allelic backgrounds, w lu ch differed only at 
the site of the COL7Al flanking m arker, D3S2. T lus is also 
consistent with the mutations having atisen on a common allele in 
this population , with recombination at the D3S2 locus at some 
stage during its propagation through th e British population. T he 
analys is of microsatellite m arkers D3S1235 and D3S1581 gives 
furth er support to the existen ce of a common 7786deiG mutan t 
allele in these families. 
Overall review of the haplotype analysis showed evidence of 
recombination at the telo m eric D3F22 locus in 3 of34 alleles of the 
offspring stu died . Although occasional recombin ation at the cen-
tromeric D3S2 locus has been described previo usly in other DEB 
patients (Hovnatuan el a/, 1995) , to o ur knowledge tlus is the first 
report of recombination ofD3F22. T hi s has impli cations for studies 
that use this m arker for COL 7 A1 linkage analysis . In particular, this 
has relevance for prenatal diagnosis of recessive DEB, in whi ch 
D3F22 may be used as an informative marker for the pathogenetic 
mutation(s) (Christiano el a/, 1996). 
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T he high reh1tive freq uencies ofR578X and 7786dciG found in 
this stu dy represen t the first recurrent mutations of COL7A1 in 
British patients with recessive DEB. T his has significance fo r future 
mutation-detection stra tegies . Specifically, Br;tish patients with this 
disease should be screened initially by PCR ampli fication and 
restd c tion analysis fo r the presence of these two .COL 7 A 1 muta-
tions. Such analysis may avoid the need for mor~ exhaustive 
screening of the remaining exons of this gene in a substantial 
number of patients with DEB. 
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